论文部分内容阅读
目的观察参附注射液对治疗非小细胞肺癌患者的疗效以及生活质量的影响。方法将54例非小细胞肺癌患者随机分为联合参附注射液化疗治疗组和单纯化疗组,通过同一化疗方案化疗后,观察两组化疗病人的疗效及化疗对生活质量的影响,比较两组差异有无统计学意义。结果两组化疗有效率、疾病进展时间上差异均有统计学意义(P<0.05),在中位生存期和1年、2年生存率上差异无统计学意义(P>0.05)。结论联合使用参附注射液化疗对非小细胞肺癌能够明显提高化疗疗效,对改善患者的生活质量有一定的积极意义。
Objective To observe the effect of Shenfu injection on curative effect and quality of life in patients with non-small cell lung cancer. Methods Fifty-four patients with non-small cell lung cancer were randomly divided into combined Shenfu injection chemotherapy group and chemotherapy alone group. After the same chemotherapy regimen, the curative effect and the effect of chemotherapy on the quality of life of two groups of chemotherapy patients were observed. The difference was statistically significant. Results There was significant difference between two groups in chemotherapy efficiency and disease progression time (P <0.05). There was no significant difference in median survival time, 1 year, 2 year survival rate between the two groups (P> 0.05). Conclusion Shenfu injection combined with chemotherapy for non-small cell lung cancer can significantly improve the efficacy of chemotherapy, to improve the quality of life of patients with some positive.